Publications by authors named "Matilde Cossutta"

Claim this Profile
U
Ultrasonographic hip morphology in mucopolysaccharidosis type I Hurler after hematopoietic stem cell gene therapy.
Maurizio De Pellegrin, Chiara Filisetti, Matilde Cossutta, Michele Colombo, Giulia Consiglieri

J Child Orthop· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-neurological, non-skeletal outcomes after hematopoietic stem and progenitor cell-gene therapy (OTL-203) for Hurler syndrome.
Francesca Tucci, M Luz Uria Oficialdegui, Giulia Consiglieri, Matilde Cossutta, Chiara Filisetti

Mol Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and Future Perspective in Hematopoietic Stem Progenitor Cell-gene Therapy for Inborn Errors of Metabolism.
Francesca Tucci, Giulia Consiglieri, Matilde Cossutta, Maria Ester Bernardo

Hemasphere· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The blood count as a compass to navigate in the ever-changing landscape of the carrier state of hemoglobinopathies: a single-center Italian experience.
Silvio Marchesani, Margherita Di Mauro, Giulia Ceglie, Ginevra Grassia, Michaela Carletti, Matilde Cossutta

Front Pediatr· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunological profile in a pediatric population of patients with spherocytosis. A single-center experience.
Silvio Marchesani, Letizia Sabatini, Valentina Bertaina, Olivia Marini, Michela Ambrosi, Matilde Cossutta

Blood Cells Mol Dis· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory status in pediatric sickle cell disease: Unravelling the role of immune cell subsets.
Silvio Marchesani, Valentina Bertaina, Olivia Marini, Matilde Cossutta, Margherita Di Mauro

Front Mol Biosci· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab vedotin as a single agent in the treatment of a pediatric primary cutaneous CD30 lymphoproliferative disorder: A case report.
Giulia Ceglie, Rita De Vito, Matilde Cossutta, Alice Tiberi, Roberto Carta

Pediatr Blood Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis